Despite 2 (two) recent Nationwide Class-1 Recalls of BBraun Infusomat IV pumps issued by the US Food and Drug Administration on November 17, 2023 and on December 13, 2023, due to HIGHLY DEADLY design flaw causing “interruption to the infusion of high-risk medications” that may lead to “permanent impairment to body structures or body functions”, is “life-threatening”, and “may lead to death", the Kaiser Permanente continues to use HIGHLY DEADLY BBraun IV pumps in virtually all of its Northern California facilities ignoring the FDA's Nationwide Recall and numerous incidents reported by Kaiser Nurses proving that due to numerous design flaws, BBraun IV pumps compromise the safety of Kaiser patients by exposing them to:

1. High risk of deadly errors as evidenced by the US Food and Drug Administration advisory and Class-1 recalls issued on November 17th , 2023 and December 13, 2023.

2. Delays of care,

3. Elevated risk of not receiving the ordered doses of IV medications,

4. Prolonged length of hospital stays,

5. Elevated risk of developing antibiotic-resistant infections (super infections) in cases where BBraun malfunctions result in interruptions of antibiotic administrations, and delivery of lower than ordered doses of antibiotics,

6. Elevated risk for re-admission, and

7. High risk of patient death or injury due to frequent malfunctions such as bolus behavior, under-infusion of medications, and false alarms that stop the infusion of life-sustaining medications.

Therefore, to ensure the safety of Kaiser Patients we petition for immediate removal of BBraun IV pumps from all Kaiser Facilities, and for bringing back highly efficient and safe Alaris CareFusion IV pumps that are being used by approximately 80% of the US healthcare facilities because of their proven reliability and safety.